InvestorsHub Logo
icon url

HappyLibrarian

10/19/23 2:29 PM

#642011 RE: ae kusterer #642001

No one has adequately explained why anyone is impressed that Dr. Liau joining the SAB is a big deal.

She already has a huge stake in DCVax-L succeeding and Direct moving forward because they are her life’s work.

Now if a former critic like Dr. Buzdar joined and made a favorable statement while doing, that would be with noticing.
icon url

dennisdave

10/19/23 3:40 PM

#642039 RE: ae kusterer #642001

Bright Boy is correct; the stock should be $5 . The almost zero notations by the HTA inspectors suggests that Sawston is one of the best run cell based immunotherapy factories in the world.

Sure if Advent were an NWBO subsidiary then NWBO stock might have been very well at $5. Unfortunately, Advent is a Toucan/LP subsidiary paid by NWBO shareholders and thus we, NWBO shareholders, gain nothing in market value from Advent being a wonderful "cell-run-based immunotherapy factory". I bet Advent is worth more than NWBO's current market cap. Yes Linda really stole money out of the pockets from NWBO shareholders.
icon url

exwannabe

10/19/23 3:40 PM

#642040 RE: ae kusterer #642001

Yesterday's HTA inspection report ranks up there with the importance of the recent Liau joining the SAB announcement.


So the HTA inspection noted that Advent only had 2 minor infractions in importing frozen tumor samples. And that no other HTA activities were performed.

How hard is it to import frozen material?

Now, if they said anything about manufacturing with it, then you would have a modest point. But everything other than just import is noted as not being actively performed.